Effects of treatment with fluoride on bone mineral density and fracture risk - A meta-analysis

Osteoporosis International

Volumn 19, Issue 3, 2008, Pages 257-268

  Vestergaard, P ^a   Jorgensen, N R ^b,c   Schwarz, P ^c   Mosekilde, L ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Fluoride; Fracture; Meta analysis; Meta regression; Monofluorophosphate; Sodium fluoride

Indexed keywords

CALCITONIN; CALCIUM; ETIDRONIC ACID; FLUORIDE; FLUORIDE SODIUM; FLUOROPHOSPHATE; GLUCOCORTICOID; IBANDRONIC ACID; PLACEBO; VITAMIN D;

ARTHRALGIA; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; DRUG FORMULATION; DUAL ENERGY X RAY ABSORPTIOMETRY; GASTROINTESTINAL SYMPTOM; HIP FRACTURE; HUMAN; LEG PAIN; META ANALYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLOW DRUG RELEASE; SPINE FRACTURE; SPINE RADIOGRAPHY; SYSTEMATIC REVIEW; TREATMENT DURATION; VERTEBRA FRACTURE;

BONE DENSITY; FLUORIDES; FRACTURES, BONE; HIP JOINT; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SPINAL FRACTURES; SPINE;

EID: 39049148545     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-007-0437-6     Document Type: Article

References (51)

1. Haguenauer D, Welch V, Shea B et al (2000) Fluoride for the treatment of postmenopausal osteoporotic fractures: a meta-analysis. Osteoporos Int 11:727-738
2. Meunier PJ, Roux C, Seeman E et al (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459-468
3. Posner AS (1996) The effect of fluoride on bone mineralisation. In: Fejerskov O, Ekstrand J, Burt BA (eds) Fluoride in dentistry, 1st edn. Munksgaard, Copenhagen, pp 88-96
4. Qu H, Wie M (2006) The effect of fluoride contents in fluoridated hydroxyapatite on osteoblast behavior. Acta Biomater 2:113-119
5. Kassem M, Mosekilde L, Eriksen EF (1994) Effects of fluoride on human bone cells in vitro: differences in responsiveness between stromal osteoblast precursors and mature osteoblasts. Eur J Endocrinol 130:381-386
6. Khokher MA, Dandona P (1990) Fluoride stimulates 2H-thymidine incorporation and alkaline phosphatase production by human osteoblasts. Metabolism 39:1118-1121
7. Eriksen EF, Mosekilde L, Melsen F (1985) Effect of sodium fluoride, calcium, phosphate and vitamin D2 on trabecular bone balance and remodeling in osteoporotics. Bone 6:381-389
8. Charles P, Mosekilde L, Jensen FT (1985) The effects of sodium fluoride, calcium phosphate, and vitamin D2 for one to two years on calcium and phosphorus metabolism in postmenopausal women with spinal crush fracture osteoporosis. Bone 6:201-206
9. Briancon D, Meunier PJ (1981) Treatment of osteoporosis with fluoride, calcium, and vitamin D. Orthop Clin North Am 12:629-648
10. Vesterby A, Gundersen HJG, Melsen F, Mosekilde L (1991) Marrow space star volume in iliac crest decreases in osteoporotic patients after continuous treatment with fluoride, calcium and vitamin. Bone 12:33-37
11. Melsen F, Eriksen EF, Mosekilde L (1996) Clinical aspects of fluoride in bone. In: Fejerskov O, Ekstrand J, Burt BA (eds) Fluoride in dentristy, 1st edn. Munksgaard,Copenhagen, pp 96-111
12. Sogaard CH, Mosekilde L, Richards A, Mosekilde L (1994) Marked decrease in trabecular bone quality after five years of sodium fluoride therapy - assessed by biomechanical testing of iliac crest bone biopsies in osteoporotic patients. Bone 15:393-399
13. Schnitzler CM, Solomon L (1985) Trabecular stress fractures during fluoride therapy for osteoporosis. Skeletal Radiol 14:276-279
14. Haguenauer D, Welch V, Shea B, Tugwell P, Wells G (2000) Fluoride for treating postmenopausal osteoporosis. Cochrane Database Syst Rev CD002825
15. Riggs BL, Seeman E, Hodgson SF, Taves DR, O'Fallon WM (1982) Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. N Engl J Med 306:446-450
16. Grove O, Halver B (1981) Relief of osteoporotic backache with fluoride, calcium, and calciferol. Acta Med Scand 209:469-471
17. Christiansen C, Christensen MS, McNair P et al (1980) Prevention of early bone postmenopausal loss: controlled 2-year study in 315 normal females. European J Clin Invest 10:273-279
18. Böhning D (2000) Computer-assisted analysis of mixtures and applications: meta-analysis, disease mapping and others, 1st edn. Chapman&Hall/CRC, Boca Raton
19. Griffith LE, Walter SD (1997) The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol 50:683-691
20. Knapp G, Hartung J (2003) Improved tests for a random effects meta-regression with a single covariate. Stat Med 22:2693-2710
21. Siddiqi A, Burrin JM, Noonan K et al (1997) A longitudinal study of markers of bone turnover in Graves' disease and their value in predicting bone mineral density. J Clin Endocrinol Metab 82:753-759
22. Jowsey J, Riggs BL, Kelly PJ, Hoffman DL (1972) Effect of combined therapy with sodium fluoride, vitamin D and calcium in osteoporosis. Am J Med 53:43-49
23. Riggs BL, Hodgson SF, O'Fallon WM et al (1990) Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 322:802-809
24. Orcel P, De Vernejoul MC, Prier A et al (1990) Stress fractures of lower limbs in osteoporotic patients treated with fluoride. J Bone Miner Res 5:S91-S94
25. Vestergaard P, Jorgensen NR, Mosekilde L, Schwarz P (2007) Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk - a meta-analysis. Osteoporos Int 18:45-57
26. O'Donnell S, Cranney A, Wells GA, Adachi JD, Reginster JY (2006) Strontium ranelate for preventing and treating postmenopausal osteoporosis. Cochrane Database Syst Rev CD005326
27. Abitbol V, Mary JY, Roux C et al (2002) Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride. Aliment Pharmacol Ther 16:919-927
28. Adachi JD, Bell MJ, Bensen WG et al (1997) Fluoride therapy in prevention of rheumatoid arthritis induced bone loss. J Rheumatol 24:2308-2313
29. Adachi JD, Bell MJ, Bensen WG, et al (1996) A randomized, double-blind, placebo-controlled trial of the effects of fluoride on lumbar spine bone mineral density in patients with rheumatoid arthritis. Arthritis Rheum 39:661
30. Alexandersen P, Riis BJ, Christiansen C (1999) Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study. J Clin Endocrinol Metab 84:3013-3020
31. Gambacciani M, Spinetti A, Taponeco F et al (1995) Treatment of postmenopausal vertebral osteopenia with monofluorophospate: a long-term calcium-controlled study. Osteoporos Int 5:467-471
32. Guanabens N, Pares A, Monegal A et al (1997) Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years. Gastroenterology 113:219-224
33. Guanabens N, Farrerons J, Perez-Edo L et al (2000) Cyclical etidronate versus sodium fluoride in established postmenopausal osteoporosis: a randomized 3 year trial. Bone 27:123-128
34. Guaydier-Souquieres G, Kotzki PO, Sabatier JP, Basse-Cathalinat B, Loeb G (1996) In corticosteroid-treated respiratory diseases, monofluorophosphate increases lumbar bone density: a double-masked randomized study. Osteoporos Int 6:171-177
35. Gutteridge DH, Stewart GO, Prince RL et al (2002) A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fractures. Osteoporos Int 13:158-170
36. Hansson T, Roos B (1987) The effect of fluoride and calcium on spinal bone mineral content: a controlled, prospective (3 years) study. Calcif Tissue Int 40:315-317
37. Kleerekoper M, Peterson EL, Nelson DA et al (1991) A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis. Osteoporos Int 1:155-161
38. Lems WF, Jacobs JW, Bijlsma JW et al (1997) Is addition of sodium fluoride to cyclical etidronate beneficial in the treatment of corticosteroid induced osteoporosis? Ann Rheum Dis 56:357-363
39. Lems WF, Jacobs WG, Bijlsma JW et al (1997) Effect of sodium fluoride on the prevention of corticosteroid-induced osteoporosis. Osteoporos Int 7:575-582
40. Lippuner K, Haller B, Casez JP, Montandon A, Jaeger P (1996) Effect of disodium monofluorophosphate, calcium and vitamin D supplementation on bone mineral density in patients chronically treated with glucocorticosteroids: a prospective, randomized, double-blind study. Miner Electrolyte Metab 22:207-213
41. Mamelle N, Dusan R, Martin JL et al (1988) Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis. Lancet 2:361-365
42. Meunier PJ, Sebert JL, Reginster JY et al (1998) Fluoride salts are no better at preventing new vertebral fractures than calcium-vitamin D in postmenopausal osteoporosis: the FAVOStudy. Osteoporos Int 8:4-12
43. Pak CY, Sakhaee K, Adams-Huet B et al (1995) Treatment of postmenopausal osteoporosis with slow-release sodium fluoride. Final report of a randomized controlled trial. Ann Intern Med 123:401-408
44. Reginster JY, Meurmans L, Zegels B et al (1998) The effect of sodium monofluorophosphate plus calcium on vertebral fracture rate in postmenopausal women with moderate osteoporosis. A randomized, controlled trial. Ann Intern Med 129:1-8
45. Ringe JD, Dorst A, Kipshoven C, Rovati LC, Setnikar I (1998) Avoidance of vertebral fractures in men with idiopathic osteoporosis by a three year therapy with calcium and low-dose intermittent monofluorophosphate. Osteoporos Int 8:47-52
46. Ringe JD, Kipshoven C, Coster A, Umbach R (1999) Therapy of established postmenopausal osteoporosis with monofluorophosphate plus calcium: dose-related effects on bone density and fracture rate. Osteoporos Int 9:171-178
47. Ringe JD, Dorst A, Faber H et al (2005) Efficacy of etidronate and sequential monofluorophosphate in severe postmenopausal osteoporosis: a pilot study. Rheumatol Int 25:296-300
48. Sebert JL, Richard P, Mennecier I, Bisset JP, Loeb G (1995) Monofluorophosphate increases lumbar bone density in osteopenic patients: a double-masked randomized study. Osteoporos Int 5:108-114
49. Von Tirpitz C, Klaus J, Bruckel J et al (2000) Increase of bone mineral density with sodium fluoride in patients with Crohn's disease. Eur J Gastroenterol Hepatol 12:19-24
50. Von Tirpitz C, Klaus J, Steinkamp M et al (2003) Therapy of osteoporosis in patients with Crohn's disease: a randomized study comparing sodium fluoride and ibandronate. Aliment Pharmacol Ther 17:807-816
51. Jadad AR, Moore RA, Carroll D et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1-12